ZYPREXA 10 mg, powder for solution for injection bottle
Active ingredients: Olanzapine
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injectionbottleintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZYPREXA 10 mg, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- CHEPLAPHARM REGISTRATION (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Jan 2004
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63739570CIP73575497CIP133400935754974Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OLANZAPINEpoudre | 10 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.